Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Narcotic Antagonists"" wg kryterium: Temat


Tytuł :
The lasting impact of methocinnamox on opioid self-administration.
Autorzy :
Townsend EA; Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA. .
Pokaż więcej
Źródło :
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2020 Nov; Vol. 45 (12), pp. 1963-1964. Date of Electronic Publication: 2020 May 22.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Comment
MeSH Terms :
Fentanyl*
Narcotic Antagonists*
Analgesics, Opioid ; Animals ; Cinnamates ; Macaca mulatta ; Morphine Derivatives ; Receptors, Opioid, mu
Czasopismo naukowe
Tytuł :
Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.
Autorzy :
Moustaqim-Barrette A; BC Centre for Disease Control, Vancouver, BC, Canada.
Papamihali K; BC Centre for Disease Control, Vancouver, BC, Canada.
Mamdani Z; BC Centre for Disease Control, Vancouver, BC, Canada.
Williams S; BC Centre for Disease Control, Vancouver, BC, Canada.
Buxton JA; BC Centre for Disease Control, Vancouver, BC, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Sep 11; Vol. 15 (9), pp. e0238618. Date of Electronic Publication: 2020 Sep 11 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Overdose/*drug therapy
Naloxone/*therapeutic use
Narcotic Antagonists/*therapeutic use
Opioid-Related Disorders/*drug therapy
Adult ; British Columbia/epidemiology ; Drug Overdose/epidemiology ; Drug Overdose/prevention & control ; Female ; Harm Reduction ; Humans ; Male ; Middle Aged ; Naloxone/adverse effects ; Narcotic Antagonists/adverse effects ; Opioid-Related Disorders/epidemiology ; Opioid-Related Disorders/prevention & control ; Pharmacies/trends
Czasopismo naukowe
Tytuł :
When Prescribing Isn't Enough - Pharmacy-Level Barriers to Buprenorphine Access.
Autorzy :
Cooper HLF; From the Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health at Emory University, Atlanta (H.L.F.C., D.H.C.); and the Department of Epidemiology, University of Kentucky College of Public Health (A.M.Y.) and the Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy (P.R.F.) - both in Lexington.
Cloud DH; From the Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health at Emory University, Atlanta (H.L.F.C., D.H.C.); and the Department of Epidemiology, University of Kentucky College of Public Health (A.M.Y.) and the Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy (P.R.F.) - both in Lexington.
Young AM; From the Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health at Emory University, Atlanta (H.L.F.C., D.H.C.); and the Department of Epidemiology, University of Kentucky College of Public Health (A.M.Y.) and the Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy (P.R.F.) - both in Lexington.
Freeman PR; From the Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health at Emory University, Atlanta (H.L.F.C., D.H.C.); and the Department of Epidemiology, University of Kentucky College of Public Health (A.M.Y.) and the Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy (P.R.F.) - both in Lexington.
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2020 Aug 20; Vol. 383 (8), pp. 703-705.
Typ publikacji :
Journal Article
MeSH Terms :
Health Policy*
Legislation, Drug*
Opiate Substitution Treatment*
Pharmacies*
Buprenorphine/*supply & distribution
Health Services Accessibility/*statistics & numerical data
Narcotic Antagonists/*supply & distribution
Opioid-Related Disorders/*drug therapy
Appalachian Region ; Buprenorphine/therapeutic use ; Humans ; Interprofessional Relations ; Medical Overuse/legislation & jurisprudence ; Narcotic Antagonists/therapeutic use ; Pharmacists ; Physicians ; Stereotyping ; Trust ; United States ; United States Government Agencies
Czasopismo naukowe
Tytuł :
Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
Autorzy :
Vijayvargiya P; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, MN, USA.
Camilleri M; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, MN, USA.
Vijayvargiya P; Department of Internal Medicine, Emory University, Atlanta, GA, USA.
Erwin P; Division of Library Services, Mayo Clinic, Rochester, MN, USA.
Murad MH; Evidence Based Practice Center, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Jul; Vol. 52 (1), pp. 37-53. Date of Electronic Publication: 2020 May 27.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Analgesics, Opioid/*adverse effects
Constipation/*drug therapy
Laxatives/*therapeutic use
Narcotic Antagonists/*therapeutic use
Receptors, Opioid, mu/*antagonists & inhibitors
Constipation/chemically induced ; Humans ; Laxatives/adverse effects ; Narcotic Antagonists/adverse effects ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Autorzy :
Patnode CD; Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.
Perdue LA; Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.
Rushkin M; Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.
Dana T; Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland.
Blazina I; Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland.
Bougatsos C; Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland.
Grusing S; Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland.
O'Connor EA; Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.
Fu R; Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland.; School of Public Health, Oregon Health & Science University-Portland State University, Portland.
Chou R; Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland.; Division of General Internal Medicine and Geriatrics, Oregon Health & Science University, Portland.
Pokaż więcej
Źródło :
JAMA [JAMA] 2020 Jun 09; Vol. 323 (22), pp. 2310-2328.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.; Systematic Review
MeSH Terms :
Psychotherapy*
Mass Screening/*standards
Narcotic Antagonists/*therapeutic use
Substance Abuse Detection/*standards
Substance-Related Disorders/*diagnosis
Adolescent ; Adult ; Female ; Humans ; Mass Screening/adverse effects ; Mass Screening/methods ; Naloxone/adverse effects ; Naloxone/therapeutic use ; Narcotic Antagonists/adverse effects ; Practice Guidelines as Topic ; Pregnancy ; Sensitivity and Specificity ; Substance Abuse Detection/methods ; Substance-Related Disorders/drug therapy ; Substance-Related Disorders/prevention & control ; Substance-Related Disorders/therapy ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement.
Autorzy :
Krist AH; Fairfax Family Practice Residency, Fairfax, Virginia.; Virginia Commonwealth University, Richmond.
Davidson KW; Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York.
Mangione CM; University of California, Los Angeles.
Barry MJ; Harvard Medical School, Boston, Massachusetts.
Cabana M; University of California, San Francisco.
Caughey AB; Oregon Health & Science University, Portland.
Curry SJ; University of Iowa, Iowa City.
Donahue K; University of North Carolina at Chapel Hill.
Doubeni CA; Mayo Clinic, Rochester, Minnesota.
Epling JW Jr; Virginia Tech Carilion School of Medicine, Roanoke.
Kubik M; Temple University, Philadelphia, Pennsylvania.
Ogedegbe G; New York University, New York, New York.
Pbert L; University of Massachusetts Medical School, Worcester.
Silverstein M; Boston University, Boston, Massachusetts.
Simon MA; Northwestern University, Evanston, Illinois.
Tseng CW; University of Hawaii, Honolulu.; Pacific Health Research and Education Institute, Honolulu, Hawaii.
Wong JB; Tufts University School of Medicine, Boston, Massachusetts.
Pokaż więcej
Corporate Authors :
US Preventive Services Task Force
Źródło :
JAMA [JAMA] 2020 Jun 09; Vol. 323 (22), pp. 2301-2309.
Typ publikacji :
Journal Article; Practice Guideline
MeSH Terms :
Psychotherapy*
Mass Screening/*standards
Narcotic Antagonists/*therapeutic use
Substance Abuse Detection/*standards
Substance-Related Disorders/*diagnosis
Adolescent ; Adult ; Humans ; Mass Screening/adverse effects ; Mass Screening/methods ; Narcotic Antagonists/adverse effects ; Sensitivity and Specificity ; Substance Abuse Detection/methods ; Substance-Related Disorders/drug therapy ; Substance-Related Disorders/therapy ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Evaluating naloxegol for the treatment of opioid-induced constipation.
Autorzy :
Daniali M; Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences , Tehran, Iran.; Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences , Tehran, Iran.
Nikfar S; Evidence-Based Evaluation of Cost-Effectiveness and Clinical Outcomes Group, Pharmaceutical Sciences Research Center (PSRC), and the Pharmaceutical Management and Economics Research Center (PMERC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences , Tehran, Iran.; Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences , Tehran, Iran.; Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences , Tehran, Iran.
Abdollahi M; Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences , Tehran, Iran.; Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences , Tehran, Iran.; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences , Tehran, Iran.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2020 Jun; Vol. 21 (8), pp. 883-891. Date of Electronic Publication: 2020 Mar 04.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Analgesics, Opioid/*adverse effects
Morphinans/*therapeutic use
Narcotic Antagonists/*therapeutic use
Opioid-Induced Constipation/*drug therapy
Polyethylene Glycols/*therapeutic use
Receptors, Opioid, mu/*antagonists & inhibitors
Analgesics, Opioid/therapeutic use ; Humans ; Laxatives/therapeutic use ; Morphinans/administration & dosage ; Narcotic Antagonists/administration & dosage ; Opioid-Induced Constipation/metabolism ; Pain/drug therapy ; Polyethylene Glycols/administration & dosage
Czasopismo naukowe
Tytuł :
Carfentanil toxicity in the African green monkey: Therapeutic efficacy of naloxone.
Autorzy :
Langston JL; United States Army Medical Research Institute of Chemical Defense, 8350 Ricketts Point Rd, Aberdeen Proving Ground, MD, 21010, United States.
Moffett MC; United States Army Medical Research Institute of Chemical Defense, 8350 Ricketts Point Rd, Aberdeen Proving Ground, MD, 21010, United States.
Makar JR; United States Army Medical Research Institute of Chemical Defense, 8350 Ricketts Point Rd, Aberdeen Proving Ground, MD, 21010, United States.
Burgan BM; United States Army Medical Research Institute of Chemical Defense, 8350 Ricketts Point Rd, Aberdeen Proving Ground, MD, 21010, United States.
Myers TM; United States Army Medical Research Institute of Chemical Defense, 8350 Ricketts Point Rd, Aberdeen Proving Ground, MD, 21010, United States. Electronic address: .
Pokaż więcej
Źródło :
Toxicology letters [Toxicol Lett] 2020 Jun 01; Vol. 325, pp. 34-42. Date of Electronic Publication: 2020 Feb 15.
Typ publikacji :
Journal Article
MeSH Terms :
Analgesics, Opioid/*toxicity
Fentanyl/*analogs & derivatives
Naloxone/*therapeutic use
Narcotic Antagonists/*therapeutic use
Analgesics, Opioid/antagonists & inhibitors ; Animals ; Apnea/chemically induced ; Apnea/prevention & control ; Behavior, Animal/drug effects ; Chlorocebus aethiops ; Conditioning, Operant/drug effects ; Drug Overdose/drug therapy ; Fentanyl/antagonists & inhibitors ; Fentanyl/toxicity ; Male ; Naloxone/toxicity ; Narcotic Antagonists/toxicity ; Reaction Time/drug effects
Czasopismo naukowe
Tytuł :
A Practical Approach for the Management of the Mixed Opioid Agonist-Antagonist Buprenorphine During Acute Pain and Surgery.
Autorzy :
Warner NS; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN; Division of Pain Medicine, Mayo Clinic, Rochester, MN; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN. Electronic address: .
Warner MA; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN; Division of Critical Care Medicine, Mayo Clinic, Rochester, MN.
Cunningham JL; Department of Pharmacy, Mayo Clinic, Rochester, MN.
Gazelka HM; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN; Division of Pain Medicine, Mayo Clinic, Rochester, MN.
Hooten WM; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN; Division of Pain Medicine, Mayo Clinic, Rochester, MN.
Kolla BP; Department of Psychiatry, Mayo Clinic, Rochester, MN.
Warner DO; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN; Division of Pediatric Anesthesiology, Mayo Clinic, Rochester, MN.
Pokaż więcej
Źródło :
Mayo Clinic proceedings [Mayo Clin Proc] 2020 Jun; Vol. 95 (6), pp. 1253-1267. Date of Electronic Publication: 2020 Feb 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Acute Pain/*drug therapy
Buprenorphine/*adverse effects
Narcotic Antagonists/*adverse effects
Pain, Postoperative/*drug therapy
Acute Pain/complications ; Buprenorphine/administration & dosage ; Dose-Response Relationship, Drug ; Female ; Humans ; Male ; Narcotic Antagonists/administration & dosage ; Opiate Substitution Treatment/adverse effects ; Opioid-Related Disorders/complications ; Opioid-Related Disorders/drug therapy ; Pain, Postoperative/complications
Czasopismo naukowe
Tytuł :
Regional variation in states' naloxone accessibility laws in association with opioid overdose death rates-Observational study (STROBE compliant).
Autorzy :
You HS; Department of Family Medicine, Chungbuk National University Hospital, Cheongju, Chungbuk.
Ha J; Department of Medicine, Korea University College of Medicine, Seoul, Korea.
Kang CY; School of Medicine.
Kim L; School of Medicine.
Kim J; School of Medicine.
Shen JJ; Department of Health Care Administration and Policy, School of Public Health.
Park SM; Department of Criminal Justice, Greenspun College of Urban Affairs, University of Nevada Las Vegas, Nevada.
Chun SY; School of Medicine.
Hwang J; Department of Thoracic and Cardiovascular Surgery, Korea University College of Medicine.
Yamashita T; Department of Sociology, Anthropology, and Health Administration and Policy, University of Maryland Baltimore County, Baltimore, Maryland.
Lee SW; Department of Physical Medicine and Rehabilitation, Mountain View Hospital.
Dounis G; School of Dental Medicine, University of Nevada Las Vegas, Las Vegas, Nevada.
Lee YJ; Department of Family Medicine, Yonsei University College of Medicine.
Han DH; Department of Health Care Administration and Policy, School of Public Health.; Deparment of Preventive Dentistry, School of Dentistry, Seoul National University, Seoul, Korea.
Byun D; Department of Medicine, Southern Nevada Veterans Affairs Health System, North Las Vegas, Nevada.
Yoo JW; Department of Internal Medicine, University of Nevada Las Vegas School of Medicine, 1701 W. Charleston Blvd Ste 230, Las Vegas, NV.
Kang HT; Department of Family Medicine, Chungbuk National University Hospital, Cheongju, Chungbuk.; Department of Health Care Administration and Policy, School of Public Health.; Department of Medicine, Chungbuk National University College of Medicine, Cheongju, Chungbuk, Korea.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 May 29; Vol. 99 (22), pp. e20033.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Analgesics, Opioid/*poisoning
Drug Overdose/*mortality
Health Services Accessibility/*legislation & jurisprudence
Naloxone/*supply & distribution
Narcotic Antagonists/*supply & distribution
Cross-Sectional Studies ; Drug Overdose/drug therapy ; Health Services Accessibility/trends ; Humans ; Naloxone/therapeutic use ; Narcotic Antagonists/therapeutic use ; Retrospective Studies ; State Government ; United States
Czasopismo naukowe
Tytuł :
Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users.
Autorzy :
Acharya M; Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Chopra D; Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Hayes CJ; Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Teeter B; Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Martin BC; Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: .
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Apr; Vol. 23 (4), pp. 451-460. Date of Electronic Publication: 2020 Feb 10.
Typ publikacji :
Journal Article
MeSH Terms :
Analgesics, Opioid/*administration & dosage
Drug Overdose/*prevention & control
Naloxone/*administration & dosage
Narcotic Antagonists/*administration & dosage
Administration, Intranasal ; Analgesics, Opioid/economics ; Analgesics, Opioid/poisoning ; Community Pharmacy Services/economics ; Community Pharmacy Services/organization & administration ; Cost-Benefit Analysis ; Drug Costs ; Drug Overdose/economics ; Humans ; Markov Chains ; Naloxone/economics ; Narcotic Antagonists/economics ; Opioid-Related Disorders/complications ; Opioid-Related Disorders/economics ; Quality-Adjusted Life Years ; Risk
Czasopismo naukowe
Tytuł :
Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat.
Autorzy :
Valenza M; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue - Box 171, New York, NY, 10065, USA. .
Windisch KA; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue - Box 171, New York, NY, 10065, USA. .
Butelman ER; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue - Box 171, New York, NY, 10065, USA.
Reed B; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue - Box 171, New York, NY, 10065, USA.
Kreek MJ; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue - Box 171, New York, NY, 10065, USA.
Pokaż więcej
Źródło :
Psychopharmacology [Psychopharmacology (Berl)] 2020 Apr; Vol. 237 (4), pp. 1147-1160. Date of Electronic Publication: 2020 Jan 08.
Typ publikacji :
Journal Article
MeSH Terms :
Behavior, Addictive/*drug therapy
Brain/*drug effects
Cocaine/*administration & dosage
Cocaine-Related Disorders/*drug therapy
Narcotic Antagonists/*pharmacology
Receptors, Opioid, kappa/*antagonists & inhibitors
Animals ; Behavior, Addictive/metabolism ; Brain/metabolism ; Cocaine-Related Disorders/metabolism ; Conditioning, Operant/drug effects ; Conditioning, Operant/physiology ; Dopamine Uptake Inhibitors/administration & dosage ; Male ; Narcotic Antagonists/therapeutic use ; Rats ; Rats, Sprague-Dawley ; Receptors, Opioid, kappa/metabolism ; Self Administration ; Substance Withdrawal Syndrome/drug therapy ; Substance Withdrawal Syndrome/metabolism
Czasopismo naukowe
Tytuł :
Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial.
Autorzy :
Brunette MF; Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756. .; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
Correll CU; Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, New York, USA.; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany.
O'Malley SS; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
McDonnell D; Alkermes Pharma Ireland Limited, Dublin, Ireland.
DiPetrillo L; Alkermes, Inc, Waltham, Massachusetts, USA.
Jiang Y; Alkermes, Inc, Waltham, Massachusetts, USA.
Simmons A; Alkermes, Inc, Waltham, Massachusetts, USA.
Silverman BL; Alkermes, Inc, Waltham, Massachusetts, USA.
Citrome L; New York Medical College, Valhalla, New York, USA.
Green AI; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
Pokaż więcej
Źródło :
The Journal of clinical psychiatry [J Clin Psychiatry] 2020 Mar 10; Vol. 81 (2). Date of Electronic Publication: 2020 Mar 10.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Outcome Assessment, Health Care*
Alcoholism/*drug therapy
Antipsychotic Agents/*pharmacology
Naltrexone/*analogs & derivatives
Narcotic Antagonists/*pharmacology
Olanzapine/*pharmacology
Schizophrenia/*drug therapy
Adult ; Alcoholism/epidemiology ; Antipsychotic Agents/administration & dosage ; Comorbidity ; Female ; Humans ; Male ; Middle Aged ; Naltrexone/administration & dosage ; Naltrexone/pharmacology ; Narcotic Antagonists/administration & dosage ; Olanzapine/administration & dosage ; Schizophrenia/epidemiology
Czasopismo naukowe
Tytuł :
Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study.
Autorzy :
Potkin SG; School of Medicine, University of California, Irvine, California, USA.
Kunovac J; Altea Research, Las Vegas, Nevada, USA.; Excell Research, Oceanside, California, USA.
Silverman BL; Alkermes, Inc, Waltham, Massachusetts, USA.
Simmons A; Alkermes, Inc, Waltham, Massachusetts, USA.
Jiang Y; Alkermes, Inc, Waltham, Massachusetts, USA.
DiPetrillo L; Alkermes, Inc, Waltham, Massachusetts, USA.
McDonnell D; Alkermes Pharma Ireland Limited, Connaught House, 1 Burlington Rd, Dublin D04 C5Y6, Ireland. .; Alkermes Pharma Ireland Limited, Dublin, Ireland.
Pokaż więcej
Źródło :
The Journal of clinical psychiatry [J Clin Psychiatry] 2020 Mar 03; Vol. 81 (2). Date of Electronic Publication: 2020 Mar 03.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Outcome Assessment, Health Care*
Symptom Flare Up*
Antipsychotic Agents/*pharmacology
Naltrexone/*analogs & derivatives
Narcotic Antagonists/*pharmacology
Olanzapine/*pharmacology
Schizophrenia/*drug therapy
Acute Disease ; Adult ; Antipsychotic Agents/administration & dosage ; Double-Blind Method ; Drug Combinations ; Female ; Humans ; Male ; Middle Aged ; Naltrexone/administration & dosage ; Naltrexone/pharmacology ; Narcotic Antagonists/administration & dosage ; Olanzapine/administration & dosage
Czasopismo naukowe
Tytuł :
Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.
Autorzy :
Yang JC; Cambridge Institute of Public Health, University of Cambridge, Cambridge, United Kingdom.; Department of Epidemiology and Applied Clinical Research, Division of Psychiatry, Faculty of Brain Sciences, University College London, London, United Kingdom.
Roman-Urrestarazu A; Cambridge Institute of Public Health, University of Cambridge, Cambridge, United Kingdom.
Brayne C; Cambridge Institute of Public Health, University of Cambridge, Cambridge, United Kingdom.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Mar 03; Vol. 15 (3), pp. e0229787. Date of Electronic Publication: 2020 Mar 03 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Narcotic Antagonists/*therapeutic use
Opiate Substitution Treatment/*statistics & numerical data
Opioid Epidemic/*prevention & control
Opioid-Related Disorders/*rehabilitation
Substance Abuse Treatment Centers/*statistics & numerical data
Analgesics, Opioid/adverse effects ; Buprenorphine/economics ; Buprenorphine/therapeutic use ; Cost of Illness ; Geography ; Healthcare Disparities/economics ; Healthcare Disparities/organization & administration ; Healthcare Disparities/statistics & numerical data ; Humans ; Medicaid/economics ; Medicaid/statistics & numerical data ; Methadone/economics ; Methadone/therapeutic use ; Narcotic Antagonists/economics ; Opiate Substitution Treatment/economics ; Opiate Substitution Treatment/trends ; Opioid-Related Disorders/economics ; Opioid-Related Disorders/epidemiology ; Opioid-Related Disorders/etiology ; Substance Abuse Treatment Centers/economics ; Substance Abuse Treatment Centers/organization & administration ; Surveys and Questionnaires/statistics & numerical data ; United States/epidemiology
Czasopismo naukowe
Tytuł :
In vitro evaluation of Naltrexone HCl 1% Topical Cream in XemaTop™ for psoriasis.
Autorzy :
Ip K; Professional Compounding Centers of America (PCCA), 9901 South Wilcrest Drive, Houston, TX, 77099, USA. .
Song G; Professional Compounding Centers of America (PCCA), 9901 South Wilcrest Drive, Houston, TX, 77099, USA.
Banov D; Professional Compounding Centers of America (PCCA), 9901 South Wilcrest Drive, Houston, TX, 77099, USA.
Bassani AS; Professional Compounding Centers of America (PCCA), 9901 South Wilcrest Drive, Houston, TX, 77099, USA.
Valdez BC; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Pokaż więcej
Źródło :
Archives of dermatological research [Arch Dermatol Res] 2020 Mar; Vol. 312 (2), pp. 145-154. Date of Electronic Publication: 2019 Oct 30.
Typ publikacji :
Journal Article
MeSH Terms :
Naltrexone/*pharmacology
Narcotic Antagonists/*pharmacology
Psoriasis/*drug therapy
Administration, Topical ; Cells, Cultured ; Fibroblasts/drug effects ; Humans ; Models, Biological ; Naltrexone/chemistry ; Narcotic Antagonists/chemistry ; Skin Cream/chemistry
Czasopismo naukowe
Tytuł :
An overview on medication-assisted treatment (MAT) for opioid dependence.
Autorzy :
Maiti T; Department of Psychiatry, All India Institute of Medical Sciences, Bhubaneswar, India.
Das S; Department of Clinical Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Ramasamy A; Department of Pharmacology, MDA School of Pharmacy, Latur, India.
Stanley Xavier A; Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, Sri Ramachan-dra Institute of Higher Education and Research, Chennai, India.
Kumar Behera S; Department of Clinical Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Selvarajan S; Department of Clinical Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Pokaż więcej
Źródło :
Journal of opioid management [J Opioid Manag] 2020 Mar/Apr; Vol. 16 (2), pp. 141-149.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Narcotic Antagonists*/therapeutic use
Opiate Substitution Treatment*
Opioid-Related Disorders*/drug therapy
Analgesics, Opioid ; Buprenorphine/therapeutic use ; Humans ; Methadone/therapeutic use ; Naltrexone/therapeutic use
Czasopismo naukowe
Tytuł :
[Lack of evidence for the inhibition of opioid-related analgesia through peripherally acting μ‑opioid-receptor antagonists].
Autorzy :
Überall MA; Privates Institut für Neurowissenschaften, Algesiologie und Pädiatrie, Nordostpark 51, 90411, Nürnberg, Deutschland. .
Müller-Schwefe GHH; Schmerz- und Palliativzentrum Göppingen, Schillerplatz 8/1, 73033, Göppingen, Deutschland. .
Pokaż więcej
Transliterated Title :
Keine Evidenz für die Abschwächung der analgetischen Opioidwirkung durch peripher wirksame µ‑Opioidrezeptorantagonisten.
Źródło :
Schmerz (Berlin, Germany) [Schmerz] 2020 Feb; Vol. 34 (1), pp. 84-85.
Typ publikacji :
Letter
MeSH Terms :
Analgesia*
Narcotic Antagonists*/pharmacology
Narcotic Antagonists*/standards
Analgesics, Opioid/*antagonists & inhibitors
Receptors, Opioid, mu/*antagonists & inhibitors
Opinia redakcyjna
Tytuł :
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors.
Autorzy :
Wtorek K; Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Adamska-Bartłomiejczyk A; Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Piekielna-Ciesielska J; Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Ferrari F; Department of Medical Sciences, Section of Pharmacology, University of Ferrara, 44121 Ferrara, Italy.
Ruzza C; Department of Medical Sciences, Section of Pharmacology, University of Ferrara, 44121 Ferrara, Italy.
Kluczyk A; Faculty of Chemistry, University of Wroclaw, 50-383 Wroclaw, Poland.
Piasecka-Zelga J; Institute of Occupational Medicine, Research Laboratory for Medicine and Veterinary Products in the GMP Head of Research Laboratory for Medicine and Veterinary Products, 91-348 Lodz, Poland.
Calo' G; Department of Medical Sciences, Section of Pharmacology, University of Ferrara, 44121 Ferrara, Italy.
Janecka A; Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2019 Dec 05; Vol. 24 (24). Date of Electronic Publication: 2019 Dec 05.
Typ publikacji :
Journal Article
MeSH Terms :
Analgesics*/pharmacology
Narcotic Antagonists*/chemistry
Narcotic Antagonists*/pharmacology
Neurokinin-1 Receptor Antagonists*/chemistry
Neurokinin-1 Receptor Antagonists*/pharmacology
Oligopeptides*/chemistry
Oligopeptides*/pharmacology
Receptors, Neurokinin-1*/agonists
Receptors, Neurokinin-1*/metabolism
Receptors, Opioid*/agonists
Receptors, Opioid*/metabolism
Nociception/*drug effects
Animals ; Cell Line ; Drug Tolerance ; Male ; Mice ; Mice, Inbred BALB C
Czasopismo naukowe
Tytuł :
Naloxegol for opioid-induced sphincter of Oddi spasm/dysfunction.
Autorzy :
Davies AN; Supportive & Palliative Care, Royal Surrey County Hospital, Guildford, UK .
Leach C; Supportive & Palliative Care, Royal Surrey County Hospital, Guildford, UK.
Pokaż więcej
Źródło :
BMJ supportive & palliative care [BMJ Support Palliat Care] 2019 Dec; Vol. 9 (4), pp. 365-366. Date of Electronic Publication: 2019 Jun 14.
Typ publikacji :
Journal Article
MeSH Terms :
Analgesics, Opioid/*adverse effects
Morphinans/*therapeutic use
Morphine/*adverse effects
Narcotic Antagonists/*therapeutic use
Polyethylene Glycols/*therapeutic use
Spasm/*chemically induced
Spasm/*drug therapy
Sphincter of Oddi Dysfunction/*drug therapy
Administration, Oral ; Carcinoma, Squamous Cell/complications ; Humans ; Male ; Middle Aged ; Morphinans/administration & dosage ; Mucositis/complications ; Mucositis/drug therapy ; Narcotic Antagonists/administration & dosage ; Pain/complications ; Pain/drug therapy ; Polyethylene Glycols/administration & dosage ; Sphincter of Oddi Dysfunction/chemically induced ; Sphincter of Oddi Dysfunction/physiopathology ; Tonsillar Neoplasms/complications
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies